114 related articles for article (PubMed ID: 10116423)
21. ABMT and breast cancer.
Firshein J
Healthplan; 1999; 40(4):30-3, 35-7. PubMed ID: 10557735
[No Abstract] [Full Text] [Related]
22. Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex.
Rowe JM; Rapoport AP; Ryan DH; Nilsson BI; Duerst RE; Packman CH; Abboud CN; DiPersio JF; Linder T; Wang N; Simonsson B; Liesveld JL
Bone Marrow Transplant; 1999 Nov; 24(10):1057-63. PubMed ID: 10578155
[TBL] [Abstract][Full Text] [Related]
23. The autologous blood and marrow transplant long-term follow-up clinic: a model of care for following and treating survivors of autotransplant.
Schimmer AD; Dranitsaris G; Ali V; Falconer M; Keating A
Support Care Cancer; 2002 Apr; 10(3):247-52. PubMed ID: 11904790
[TBL] [Abstract][Full Text] [Related]
24. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
25. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
[TBL] [Abstract][Full Text] [Related]
26. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
Sobecks RM; Le Beau MM; Anastasi J; Williams SF
Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
[TBL] [Abstract][Full Text] [Related]
27. Technology in medicine -- ethics, politics and reality.
Watts JL; Blanchard R; Guyatt G; Miller D; Singer P; Haynes RB; Van Loon R
Ann R Coll Physicians Surg Can; 1992 Feb; 25(1):51-4. PubMed ID: 11653977
[No Abstract] [Full Text] [Related]
28. Will insurers pay for high-tech care?
Crane M
Med Econ; 1991 Apr; 68(8):82-6. PubMed ID: 10110091
[No Abstract] [Full Text] [Related]
29. 3rd Circuit keeps split alive on autologous bone marrow transplants for breast cancer. Clark v. K-Mart Corporation.
Margolis RE
Healthspan; 1992; 9(7):21-2. PubMed ID: 10183724
[No Abstract] [Full Text] [Related]
30. Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.
Ayash LJ; Clarke M; Silver SM; Braun T; Uberti J; Ratanatharathorn V; Reynolds C; Ferrara J; Broun ER; Adams PT
Bone Marrow Transplant; 2001 May; 27(9):939-47. PubMed ID: 11436104
[TBL] [Abstract][Full Text] [Related]
31. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
Wallner PE; Konski A
J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
[TBL] [Abstract][Full Text] [Related]
32. Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumours.
Nieboer P; de Vries EG; Mulder NH; Sleijfer DT; Willemse PH; Hospers GA; Gietema JA; Sluiter WJ; van Der Graaf WT
Bone Marrow Transplant; 2001 May; 27(9):959-66. PubMed ID: 11436106
[TBL] [Abstract][Full Text] [Related]
33. [Application of IHW2 purged bone marrow to autologous bone marrow transplantation in the treatment of acute myeloid leukemia].
Jiang R; Han M; Zhao Y
Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):312-4. PubMed ID: 11243113
[TBL] [Abstract][Full Text] [Related]
34. Decreased bone mineral density is common after autologous blood or marrow transplantation.
Schimmer AD; Mah K; Bordeleau L; Cheung A; Ali V; Falconer M; Trus M; Keating A
Bone Marrow Transplant; 2001 Aug; 28(4):387-91. PubMed ID: 11571512
[TBL] [Abstract][Full Text] [Related]
35. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
Hovi L; Saarinen-Pihkala UM; Vettenranta K; Lipsanen M; Tapanainen P
Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163
[TBL] [Abstract][Full Text] [Related]
36. [The role of cost analysis in the evaluation of the development of medical technology. The case of allogenic stem-cell transplantation].
Groot MT; van Agthoven M; Löwenberg B; Willemze R; Uyl-de Groot CA
Ned Tijdschr Geneeskd; 2004 Mar; 148(10):480-4. PubMed ID: 15042895
[TBL] [Abstract][Full Text] [Related]
37. Technology on wheels: evaluating the options.
Health Technol; 1987; 1(6):231-8. PubMed ID: 10285677
[TBL] [Abstract][Full Text] [Related]
38. The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer.
Mello MM; Brennan TA
Health Aff (Millwood); 2001; 20(5):101-17. PubMed ID: 11558695
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of cancer with high-dose chemotherapy and autologous stem cell transplantation].
Geisler CH; Daugaard KG; Dickmeiss E; Ifversen M; Knudsen LM
Ugeskr Laeger; 2003 Dec; 165(50):4846-9. PubMed ID: 14716902
[No Abstract] [Full Text] [Related]
40. The soul of an HMO.
Larson E
Time; 1996 Jan; 147(4):44-52. PubMed ID: 10153782
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
